This site contains promotional information intended only for healthcare professionals resident in the United Kingdom
Menu
Close
Example of description text sitting alongside header
Example of description text sitting alongside header
Menu
Close
Example of description text sitting alongside header
Example of description text sitting alongside header
Menu
Close
Menu
Close
XELJANZ® (tofacitinib citrate) Prescribing Information and Maxtrex (methotrexate) Prescribing Information. Adverse event reporting can be found at the bottom of the page.
Tofacitinib should only be used if no suitable treatment alternatives are available in patients:
These risks are considered class effects and relevant across all approved indications of JAKi in inflammatory and dermatologic diseases.
Biography
Professor Kiely is a general rheumatologist and runs specialist clinics in difficult to manage rheumatoid arthritis, idiopathic inflammatory myositis, vasculitis and interstitial lung disease associated with rheumatic diseases. He also runs the only UK national clinic for people with haemochromatosis arthropathy.
He was a member of the NICE guideline development group for rheumatoid arthritis in 2008–09, and Quality Standards group 2011–12. He has served on several British Society for Rheumatology committees and was Associate editor for Rheumatology 2017-2019. Currently he is convenor of the eular task force to develop classification criteria for haemochromatosis arthropathy, a member of the eular task force on biopharmaceutical monitoring in inflammatory arthritis and the BSR guideline development group for management of idiopathic inflammatory myositis.
His research interests are in the fields of outcomes and optimisation of therapies for inflammatory arthritis, especially biologic and JAK inhibitors, myositis and haemochromatosis arthropathy. He lectures widely in the UK and overseas on his areas of specialist interest and since 2008 has organised tri-annual educational meetings for consultant rheumatologists in London (South), Surrey, Sussex and Kent.
Set up a PfizerPro account to access further materials and resources, and receive communication about medicines and vaccines promoted by Pfizer.
Stay up to date with the latest relevant healthcare, medical and promotional information about medicines and vaccines promoted by Pfizer.
Professor Patrick DW Kiely, PhD, FRCP, is a Consultant Rheumatologist at St George’s University Hospitals NHS Foundation Trust and Professor of Practice in Clinical Rheumatology at St George’s, University of London. He qualified in medicine from the Middlesex and University College Hospital Medical School (University of London) in 1988, attained a PhD degree from Cambridge University in 1996 and has been consultant at St George’s since 1999.
Take a look at the Xeljanz ORAL Strategy studies by clicking below.
Adverse events should be reported. Reporting forms and information can be found at www.mhra.gov.uk/yellowcard or search
for MHRA Yellow Card in Google Play or Apple App Store
Adverse events should also be reported to Pfizer Medical Information on 01304 616161
To access further materials, resources and receive communication about medicines and vaccines promoted by Pfizer.
This site is intended only for healthcare professionals resident in the United Kingdom. If you are a member of the public wishing to access information on a specific medicine, please visit www.medicines.org.uk/emc
This website is brought to you by Pfizer Limited, a company registered in England
and Wales under No. 526209 with its registered office at Ramsgate Road, Sandwich, Kent, CT13 9NJ
Copyright © 2024 Pfizer Limited. All rights reserved.
VAT registration number GB201048427
These pages are not intended for patients or for members of the general public. The healthcare professional web pages contain promotional content.
I confirm that I am a healthcare professional* resident in the United Kingdom.
If you select 'No', you will be redirected to Pfizer.co.uk where you will be able to access reference information on Pfizer's prescription medicines.
*The ABPI Code definition for healthcare professional is members of the medical, dental, pharmacy and nursing professionals and any other persons who in the course of their professional activities may administer, prescribe, purchase, recommend or supply a medicine.
PP-UNP-GBR-7812. January 2024